Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Coronavirus

NAFDAC approves Oxford/AstraZeneca COVID-19 vaccine for use in Nigeria

Omokolade AjayibyOmokolade Ajayi
2 years ago
in Coronavirus, Spotlight
Why NAFDAC may sanction bakeries nationwide, NAFDAC destroys fake products valued at N1.32 billion, COVID-19: NAFDAC to grant emergency approval for necessary products

Prof. Mojisola Adeyeye, DG NAFDAC

Share on FacebookShare on TwitterShare on Linkedin

The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the Oxford/AstraZeneca COVID-19 vaccine for use in Nigeria.

This information was made public by Bashir Ahmad, the Personal Assistant on New Media to President Muhammadu Buhari, today the 18th of February 2021.

According to his statement, the Director-General of the Agency, Dr. Mojisola Adeyeye made this decision based on the recommendation of the agency after rigorous scientific considerations conducted by NAFDAC.

READ: Nigeria allocated 16 million doses of AstraZeneca vaccine – NPHCDA

The NAFDAC has approved the use of the Oxford/AstraZeneca a COVID-19 vaccine in Nigeria, the Director-General of the Agency, Dr. Mojisola Adeyeye made the announcement today and she also stated that the vaccine can be stored at 2 to 8-degree centigrade.

— Bashir Ahmad (@BashirAhmaad) February 18, 2021

What you should know

  • According to a Bloomberg report, Dr. Adeyeye noted that the review of the shot’s efficacy was conducted by NAFDAC after the agency received the “vaccine dossier” from Serum Institute of India on Feb. 10. “COVISHIELD was found safe and well-tolerated in adults above 18 years of age.
  • Adeyeye also stated that the vaccine can be stored at 2 to 8-degree centigrade. This, however, is a major issue as the complex logistics of managing the vaccine cold chain, combined with the limited government funding may aggravate the logistical challenge of transporting and distributing those vaccines quickly in the country.
  • Nairametrics reported that the National Primary Health Care Development Agency (NPHCDA) announced that the Federal Government had finalized plans to use the AstraZeneca vaccine, based on the epidemiological assessment done by the World Health Organisation (WHO).
  • However, subsequent to the previous approval of WHO, Dr Mariangela Simao, the WHO Assistant-director general for access to medicines and health products, revealed that the WHO had finally given approval for two versions of the AstraZeneca/Oxford Covid-19 vaccine for emergency use and to be rolled out globally via COVAX.

Related

Tags: Covid-19 vaccineNAFDACNational Agency for Food and Drug Administration and ControlOxford-AstraZeneca

Comments 1

  1. Abdulrashid sabo egwa says:
    February 18, 2021 at 2:41 pm

    definitely am NCE graduate no jobs if their is any vacancy am interested pls.

    Reply

Leave a Reply Cancel reply

HFM
Mega Millions
Mega Millions
Standard
Patricia





NM newsletters

Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

Recent News

  • Emefiele replies Kano State Governor, says he doesn’t understand connection between cash swap and security issue
  • 9 people including children killed as container falls on a bus at Ojuelegba, Lagos
  • Currency Swap Deadline: CPPE says 10-day extension is inadequate

Follow us on social media:

Recent News

Emefiele replies Kano State Governor, says he doesn’t understand relationship between naira redesign and security issues

Emefiele replies Kano State Governor, says he doesn’t understand connection between cash swap and security issue

January 29, 2023
9 people including children killed as container falls on a bus at Ojuelegba, Lagos

9 people including children killed as container falls on a bus at Ojuelegba, Lagos

January 29, 2023
  • Home
  • Exclusives
  • Markets
  • Industries
  • Economy
  • Business News
  • Financial Literacy
  • Lifestyle
  • Opinions

© 2023 Nairametrics

No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds

© 2023 Nairametrics